FGEN
Price:
$8.25
Market Cap:
$33.37M
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopath...[Read more]
Industry
Biotechnology
IPO Date
2014-11-14
Stock Exchange
NASDAQ
Ticker
FGEN
According to FibroGen, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.04. This represents a change of -28.47% compared to the average of 1.46 of the last 4 quarters.
The mean historical Current Ratio of FibroGen, Inc. over the last ten years is 4.29. The current 1.04 Current Ratio has changed 2.33% with respect to the historical average. Over the past ten years (40 quarters), FGEN's Current Ratio was at its highest in in the March 2020 quarter at 11.14. The Current Ratio was at its lowest in in the June 2025 quarter at 1.04.
Average
4.29
Median
3.54
Minimum
1.47
Maximum
9.69
Discovering the peaks and valleys of FibroGen, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 136.89%
Maximum Annual Current Ratio = 9.69
Minimum Annual Increase = -54.57%
Minimum Annual Current Ratio = 1.47
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 1.47 | -3.22% |
| 2023 | 1.52 | -15.45% |
| 2022 | 1.80 | -14.31% |
| 2021 | 2.10 | -54.57% |
| 2020 | 4.63 | -32.32% |
| 2019 | 6.84 | -11.78% |
| 2018 | 7.75 | -20.06% |
| 2017 | 9.69 | 136.89% |
| 2016 | 4.09 | 37.08% |
| 2015 | 2.99 | -5.49% |
The current Current Ratio of FibroGen, Inc. (FGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.60
5-year avg
2.31
10-year avg
4.29
FibroGen, Inc.’s Current Ratio is less than Kezar Life Sciences, Inc. (7.29), less than Tempest Therapeutics, Inc. (2.11), less than Aligos Therapeutics, Inc. (4.70), less than OnKure Therapeutics, Inc. (11.45), less than Mersana Therapeutics, Inc. (1.39), less than X4 Pharmaceuticals, Inc. (3.19), less than PDS Biotechnology Corporation (2.09), greater than Celularity Inc. (0.16), less than Xilio Therapeutics, Inc. (2.20), less than Actinium Pharmaceuticals, Inc. (7.96),
| Company | Current Ratio | Market cap |
|---|---|---|
| 7.29 | $45.77M | |
| 2.11 | $15.19M | |
| 4.70 | $62.09M | |
| 11.45 | $35.63M | |
| 1.39 | $137.32M | |
| 3.19 | $43.35M | |
| 2.09 | $43.78M | |
| 0.16 | $47.46M | |
| 2.20 | $38.90M | |
| 7.96 | $45.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like FibroGen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like FibroGen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is FibroGen, Inc.'s Current Ratio?
How is the Current Ratio calculated for FibroGen, Inc. (FGEN)?
What is the highest Current Ratio for FibroGen, Inc. (FGEN)?
What is the 3-year average Current Ratio for FibroGen, Inc. (FGEN)?
What is the 5-year average Current Ratio for FibroGen, Inc. (FGEN)?
How does the current Current Ratio for FibroGen, Inc. (FGEN) compare to its historical average?